Growth Hormone Therapy for Short Stature: How It Works, Results and What to Expect

Growth hormone treatment is not appropriate for every child who is shorter than peers; the underlying cause of slow growth must be assessed first. Treatment uses daily injections of laboratory-made growth hormone and is usually continued for years, not weeks or months.
Key Takeaways
- Growth hormone treatment is not appropriate for every child who is shorter than peers; the underlying cause of slow growth must be assessed first.
- Treatment uses daily injections of laboratory-made growth hormone and is usually continued for years, not weeks or months.
- Earlier treatment often offers more opportunity for height gain because growth plates eventually close during puberty.
- Regular height measurements, blood tests and dose adjustments help clinicians balance potential benefits and risks.
- Most children tolerate treatment well, but side effects and uncommon complications require prompt medical review.
Growth hormone therapy for short stature is a prescribed treatment that can improve growth in children with confirmed growth hormone deficiency and certain other growth-related conditions. It works best when evaluation and treatment begin while the growth plates are still open, and it requires regular monitoring by a pediatric endocrinology team.
Growth Hormone Therapy for Short Stature: An Overview
Growth hormone therapy for short stature uses a synthetic form of human growth hormone, also called somatropin, to support normal growth in carefully selected children. It is most commonly used when testing confirms growth hormone deficiency, but it may also be considered for some children with specific medical conditions that affect growth. The aim is to improve growth velocity during childhood and, where possible, help the child approach a height range consistent with their individual health and family pattern.
Short stature alone does not automatically mean that a child needs treatment. Some children are naturally shorter because of family height, while others have a later-than-average growth spurt and remain healthy. A pediatric endocrinologist considers the child’s growth chart, puberty stage, bone age, family heights, medical history and test results before recommending growth hormone treatment for short stature.
Growth hormone is naturally made by the pituitary gland in the brain. It acts directly and through another hormone, insulin-like growth factor 1 (IGF-1), to support bone and tissue growth. Treatment replaces or supplements this signaling when a specialist determines that it is medically appropriate.
Who May Be a Candidate for Treatment?

Children may be evaluated for growth hormone therapy when they are growing more slowly than expected, are much shorter than children of the same age and sex, or are falling across percentiles on a growth chart. The assessment is especially important when slow growth is accompanied by delayed puberty, recurrent symptoms of an underlying illness, poor weight gain, or a history that suggests a hormonal, genetic, kidney, digestive or skeletal condition.
Confirmed childhood growth hormone deficiency is a common reason for treatment. Other approved or specialist-led uses can include certain genetic syndromes, children born small for gestational age who do not show expected catch-up growth, chronic kidney disease, and some other conditions. Each indication has its own assessment criteria, expected response and monitoring plan.
Evaluation also looks for other treatable causes of reduced growth, such as hypothyroidism, celiac disease, inflammatory bowel disease, inadequate nutrition, long-term corticosteroid use or chronic systemic disease. Addressing the underlying condition may improve growth without growth hormone, or may be needed alongside hormonal care.
- Height and weight measurements taken accurately over time
- Review of growth patterns in parents and close relatives
- Physical examination, including pubertal development
- Blood tests, and sometimes growth hormone stimulation testing
- A hand and wrist X-ray to estimate bone age
- Further imaging or genetic testing when indicated
How Growth Hormone Treatment Works: Step by Step

After diagnosis, the endocrinologist calculates an individualized treatment plan based on the child’s condition, body size, growth response and laboratory findings. The medicine is usually administered as a small injection under the skin once daily, commonly in the evening. Parents and older children are taught how to prepare the device, select injection sites and rotate locations to protect the skin.
The treatment is given at home rather than as an operation or hospital procedure. Follow-up appointments are scheduled regularly, especially early in treatment. At these visits, the clinical team checks height, weight, growth velocity, puberty progression, injection technique and possible side effects. Blood tests may be used to monitor IGF-1 levels and screen for issues such as thyroid changes when appropriate.
Dosage is not fixed permanently. It may be adjusted as the child grows, according to clinical response and safety monitoring. Missing occasional doses should be discussed with the care team; families should not double a dose unless specifically instructed to do so. Consistent administration and attendance at follow-up visits are important for a meaningful assessment of response.
For children who need coordinated endocrine care, Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals assess and treat growth-related conditions for international patients.
Expected Results and Recovery Timeline
There is no recovery period in the usual sense because growth hormone therapy is an ongoing outpatient treatment. Most children can continue school, sports and everyday activities while using it. Mild temporary discomfort or bruising at an injection site may occur, and rotating sites can help reduce this.
Response is assessed over months rather than days. In many eligible children, growth rate increases most noticeably during the first year, although the degree of change varies substantially. It depends on the diagnosis, age at treatment, dose, adherence, nutrition, pubertal stage and how much growing time remains before growth plates close.
Clinicians usually review growth progress at regular intervals and compare it with the child’s pre-treatment pattern. Treatment may continue through childhood and adolescence while there is a clear benefit and open growth plates. Some people with persistent growth hormone deficiency need reassessment after final height is reached to determine whether adult replacement treatment is necessary for metabolic health rather than height gain.
How Long Does a Child Stay on HGH?
A child often stays on HGH for several years. The exact duration depends on why treatment was started, how well the child grows, whether puberty has begun, and whether the growth plates remain open. Treatment commonly continues until growth has slowed to a near-adult rate or bone maturation indicates that further height gain is unlikely.
Children with growth hormone deficiency are monitored throughout treatment, and plans are reviewed rather than set once for life. If the response is limited, the endocrinologist checks adherence, injection technique, nutrition, thyroid function and whether another condition may be affecting growth. The clinician may adjust the plan or, in some cases, recommend stopping treatment.
When a teenager reaches adult height, growth hormone deficiency may be retested because childhood results do not always persist into adulthood. Continuing HGH after growth plates close will not make a person taller, but adult treatment can be considered in selected people with confirmed ongoing deficiency for different health reasons.
What Age Is Too Late for Growth Hormones?
Growth hormone can increase height only while the growth plates at the ends of long bones are open. Once these plates fuse, typically toward the end of puberty, height cannot be increased with HGH. For this reason, assessment should not be delayed when a child has persistent slow growth or is dropping down growth-chart percentiles.
There is no single age that is too late for every child. Puberty timing and bone maturation vary, so bone age and growth rate are more informative than chronological age alone. A pediatric endocrinologist can explain whether meaningful growth potential remains after reviewing the child’s measurements, pubertal development and bone-age X-ray.
Starting treatment at a younger age, when medically indicated, generally allows more time for growth. However, treatment should never be started solely to pursue a particular height without a proper diagnosis, realistic expectations and discussion of the possible burdens and risks.
What Is the Downside of Taking HGH?
Daily injections, regular appointments and the emotional demands of long-term treatment can be challenging for children and families. Not every child has the same growth response, and treatment cannot promise a particular final height. The decision should therefore include the child’s wellbeing, family preferences, diagnosis and expected benefit.
Many children tolerate somatropin well. Possible side effects include injection-site reactions, headaches, muscle or joint discomfort, and swelling from fluid retention. Clinicians also watch for changes in blood sugar, thyroid function and growth of pre-existing scoliosis during periods of rapid growth.
Uncommon but important complications can include severe or persistent headache with visual symptoms, hip or knee pain or limping that may suggest a hip problem, and significant swelling or breathing concerns. Growth hormone is generally avoided or used with particular caution in certain situations, including active cancer. The prescribing specialist reviews the child’s individual medical history and explains symptoms that need urgent assessment.
Is HGH a Good Treatment for Short Children?
HGH can be a good treatment for short children when there is a clear medical indication and the likely benefits outweigh the burdens and risks. It is particularly valuable for children with confirmed growth hormone deficiency, where replacement addresses a genuine hormonal problem. For other causes of short stature, the expected benefit can be more variable and should be discussed in detail with a pediatric endocrinologist.
It is not a general treatment for normal variation in height. A child who is short but growing steadily, healthy and following a family pattern may only need observation and periodic growth checks. Good nutrition, adequate sleep, age-appropriate activity and treatment of any identified chronic illness also support healthy growth, though they cannot replace missing hormone in a child with true deficiency.
A supportive approach matters alongside medical decisions. Families can avoid focusing conversations on height alone, encourage confidence in the child’s abilities and seek guidance if short stature is affecting self-esteem, school participation or social wellbeing.
When to Seek Medical Care
Parents or caregivers should arrange a medical review if a child is growing much more slowly than before, is consistently far shorter than expected for their age, or is crossing downward through growth-chart percentiles. It is also appropriate to seek advice if puberty appears unusually early, delayed, or absent compared with peers, particularly when growth is also a concern.
Prompt assessment is important for a child with severe or persistent headaches, vision changes, vomiting, unexplained weight loss, chronic diarrhea, marked fatigue, excessive thirst or urination, bone pain, a limp, or hip and knee pain. These symptoms do not necessarily indicate a hormone problem, but they warrant evaluation.
Children already receiving growth hormone should contact their healthcare team promptly for severe headache, visual disturbance, persistent vomiting, new limping, significant hip pain, or other concerning symptoms. Families should not stop or change prescribed treatment without medical advice unless urgent care clinicians advise otherwise.
Frequently asked questions
How long does a child stay on HGH?
Many children use HGH for several years, often until they have nearly completed growth and their growth plates are closing or closed. The duration is reviewed regularly and depends on the diagnosis, growth response, puberty and safety monitoring. Some children with growth hormone deficiency are reassessed after reaching adult height.
What age is too late for growth hormones?
It is too late to increase height with growth hormone once the growth plates have fused. This happens at different ages depending on puberty and bone maturation, so a bone-age assessment is more useful than age alone. A pediatric endocrinologist can assess whether growth potential remains.
What is the downside of taking HGH?
The main practical downsides are daily injections, regular monitoring and variable results. Side effects can include injection-site discomfort, headache, joint pain and fluid retention, while uncommon complications need prompt medical review. HGH should only be used under specialist supervision.
Is HGH a good treatment for short children?
HGH is an effective treatment for many children with confirmed growth hormone deficiency and selected other medical conditions. It is not automatically appropriate for a healthy child who is simply shorter than peers. A careful diagnosis helps clarify the expected benefit and whether treatment is suitable.
Can growth hormone make a child taller than their genetic potential?
Growth hormone treatment aims to support growth toward the child’s individual potential when a medical growth problem is present. It cannot reliably produce a chosen adult height or overcome closed growth plates. Family height patterns, diagnosis, puberty timing and treatment response all influence outcomes.
Are growth hormone injections painful?
The injections are given with a small needle or injection device under the skin and are usually brief. Some children notice temporary stinging, bruising or redness at the injection site. Training, correct technique and rotating injection sites can make treatment more comfortable.
References
- Pediatric Endocrine Society
- Endocrine Society
- U.S. Food and Drug Administration
- National Institute of Diabetes and Digestive and Kidney Diseases
- Merck Manual Consumer Version
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
Hormone Therapy in Turkey — costs, top hospitals & a free quote
JCI-accredited · board-certified surgeons · reply within 24h
Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.









